BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS

BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS ON METFORMIN THERAPY IN A WEST AFRICA SUB-REGION

Status

Completed

Phases

Early Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02505516

Enrollment

150

Registered

2015-07-22

Start date

2013-06-30

Completion date

2014-02-28

Last updated

2015-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer, Diabetes

Keywords

pathology

Brief summary

patients om metformin from diabetic clinic were checked for bladder cancer

Interventions

OTHERmetformin

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

SCREENING

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

25 Years to 86 Years

Healthy volunteers

Yes

Inclusion criteria

* 150 people attending diabetic clinic

Design outcomes

Primary

Measure	Time frame
Number of diabetic patients on metformin therapy	6 months

Countries

Ghana

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026